Binding affinity predictions with hybrid quantum-classical convolutional neural networks.

Area of Science:

• Computational chemistry
• Drug discovery
• Quantum machine learning

Background:

• Accurate binding affinity prediction is crucial for efficient drug design.
• Deep learning methods offer superior performance but are computationally intensive.
• Quantum machine learning presents a promising avenue for enhancing classical algorithms.

Purpose of the Study:

• To develop a novel hybrid quantum-classical convolutional neural network for drug design.
• To reduce the computational complexity and training time of binding affinity prediction models.
• To accelerate the drug discovery and development pipeline.

Main Methods:

• Implementation of a hybrid quantum-classical convolutional neural network architecture.
• Utilizing large datasets for training and validation.
• Comparative analysis against classical deep learning models.

Main Results:

• Achieved a 20% reduction in computational complexity compared to classical counterparts.
• Maintained optimal performance in binding affinity predictions.
• Demonstrated significant cost and time savings of up to 40% during the training stage.

Conclusions:

• The hybrid quantum-classical approach offers a more efficient alternative for drug design.
• This method significantly speeds up the drug discovery process.
• The developed model holds promise for practical applications in pharmaceutical research.